More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement

After seeking approval in May to settle litigations over pricing of its insulin product Humalog, Eli Lilly is facing resistance from nine US states who are asking a New Jersey federal court to delay approval of the proposed $13.5 million deal.